A staged zebrafish-mouse screening strategy for antiseizure compound prioritization.
Saved in:
| Title: | A staged zebrafish-mouse screening strategy for antiseizure compound prioritization. |
|---|---|
| Authors: | Christie CF; Neuroene Therapeutics, Kensington, MD, 20895, USA., Bendell E; Neuroene Therapeutics, Kensington, MD, 20895, USA., Renaud L; Neuroene Therapeutics, Kensington, MD, 20895, USA; Medical University of South Carolina, Charleston, SC, 29425, USA., Williamson T; Medical University of South Carolina, Charleston, SC, 29425, USA., Li X; Medical University of South Carolina, Charleston, SC, 29425, USA., Himes RA; Neuroene Therapeutics, Kensington, MD, 20895, USA., Prosser LC; Medical University of South Carolina, Charleston, SC, 29425, USA., Edwards SF; Anticonvulsant Drug Development (ADD) Program, Department of Pharmacology & Toxicology, University of Utah, 84112, USA., Metcalf CS; Anticonvulsant Drug Development (ADD) Program, Department of Pharmacology & Toxicology, University of Utah, 84112, USA., West PJ; Anticonvulsant Drug Development (ADD) Program, Department of Pharmacology & Toxicology, University of Utah, 84112, USA., Wilcox KS; Anticonvulsant Drug Development (ADD) Program, Department of Pharmacology & Toxicology, University of Utah, 84112, USA., James Chou C; Neuroene Therapeutics, Kensington, MD, 20895, USA; Medical University of South Carolina, Charleston, SC, 29425, USA. Electronic address: james@neuroenetherapeutics.com., Chan SSL; Neuroene Therapeutics, Kensington, MD, 20895, USA; Medical University of South Carolina, Charleston, SC, 29425, USA. Electronic address: sherine@neuroenetherapeutics.com. |
| Source: | Neuropharmacology [Neuropharmacology] 2026 Jun 25; Vol. 298, pp. 111085. Date of Electronic Publication: 2026 Jun 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42349747 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A staged zebrafish-mouse screening strategy for antiseizure compound prioritization. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Christie+CF%22">Christie CF</searchLink>; Neuroene Therapeutics, Kensington, MD, 20895, USA.<br /><searchLink fieldCode="AU" term="%22Bendell+E%22">Bendell E</searchLink>; Neuroene Therapeutics, Kensington, MD, 20895, USA.<br /><searchLink fieldCode="AU" term="%22Renaud+L%22">Renaud L</searchLink>; Neuroene Therapeutics, Kensington, MD, 20895, USA; Medical University of South Carolina, Charleston, SC, 29425, USA.<br /><searchLink fieldCode="AU" term="%22Williamson+T%22">Williamson T</searchLink>; Medical University of South Carolina, Charleston, SC, 29425, USA.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Medical University of South Carolina, Charleston, SC, 29425, USA.<br /><searchLink fieldCode="AU" term="%22Himes+RA%22">Himes RA</searchLink>; Neuroene Therapeutics, Kensington, MD, 20895, USA.<br /><searchLink fieldCode="AU" term="%22Prosser+LC%22">Prosser LC</searchLink>; Medical University of South Carolina, Charleston, SC, 29425, USA.<br /><searchLink fieldCode="AU" term="%22Edwards+SF%22">Edwards SF</searchLink>; Anticonvulsant Drug Development (ADD) Program, Department of Pharmacology & Toxicology, University of Utah, 84112, USA.<br /><searchLink fieldCode="AU" term="%22Metcalf+CS%22">Metcalf CS</searchLink>; Anticonvulsant Drug Development (ADD) Program, Department of Pharmacology & Toxicology, University of Utah, 84112, USA.<br /><searchLink fieldCode="AU" term="%22West+PJ%22">West PJ</searchLink>; Anticonvulsant Drug Development (ADD) Program, Department of Pharmacology & Toxicology, University of Utah, 84112, USA.<br /><searchLink fieldCode="AU" term="%22Wilcox+KS%22">Wilcox KS</searchLink>; Anticonvulsant Drug Development (ADD) Program, Department of Pharmacology & Toxicology, University of Utah, 84112, USA.<br /><searchLink fieldCode="AU" term="%22James+Chou+C%22">James Chou C</searchLink>; Neuroene Therapeutics, Kensington, MD, 20895, USA; Medical University of South Carolina, Charleston, SC, 29425, USA. Electronic address: james@neuroenetherapeutics.com.<br /><searchLink fieldCode="AU" term="%22Chan+SSL%22">Chan SSL</searchLink>; Neuroene Therapeutics, Kensington, MD, 20895, USA; Medical University of South Carolina, Charleston, SC, 29425, USA. Electronic address: sherine@neuroenetherapeutics.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220236217%22">Neuropharmacology</searchLink> [Neuropharmacology] 2026 Jun 25; Vol. 298, pp. 111085. <i>Date of Electronic Publication: </i>2026 Jun 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pergamon+Press%22">Pergamon Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0236217 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-7064 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200283908%22">00283908 </searchLink><i>NLM ISO Abbreviation: </i>Neuropharmacology <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42349747 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.neuropharm.2026.111085 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 111085 Titles: – TitleFull: A staged zebrafish-mouse screening strategy for antiseizure compound prioritization. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Christie CF – PersonEntity: Name: NameFull: Bendell E – PersonEntity: Name: NameFull: Renaud L – PersonEntity: Name: NameFull: Williamson T – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: Himes RA – PersonEntity: Name: NameFull: Prosser LC – PersonEntity: Name: NameFull: Edwards SF – PersonEntity: Name: NameFull: Metcalf CS – PersonEntity: Name: NameFull: West PJ – PersonEntity: Name: NameFull: Wilcox KS – PersonEntity: Name: NameFull: James Chou C – PersonEntity: Name: NameFull: Chan SSL IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 06 Text: 2026 Jun 25 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-7064 Numbering: – Type: volume Value: 298 Titles: – TitleFull: Neuropharmacology Type: main |
| ResultId | 1 |